This is the authors' abstract. We don't add key points for this paper.
Primary cutaneous gamma-delta T-cell lymphoma (PCGDTCL) and hepatosplenic gamma-delta T-cell lymphoma (HSGDTCL) are rare and aggressive neoplasms, both with an overall 5-year survival of 10%.1,2 Even classic presentations of PCGDTCL and HGDTCL can be a diagnostic challenge due to the rarity of the conditions, variability of immunophenotypes presented in the literature, and variety of clinical presentations.1-4 Hemophagocytic lymphohistiocytosis (HLH) is a severe condition caused by dysregulated immune activation that can be triggered by various conditions such as infections, malignancy, rheumatologic disease, and drug hypersensitivity.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: